Peter Joseph Pappas Fund established to accelerate the Foundation's research goals
The Preeclampsia Foundation is pleased to announce the establishment of the Peter Joseph Pappas Fund, a restricted fund with the primary goal of supporting research that will end pre-term deliveries due to preeclampsia and related disorders of pregnancy by 2050.
Established by Clement and Lauren Pappas of Philadelphia, PA, in honor of their son, Peter Joseph, the fund will help support new and innovative approaches to researching this age-old disease that still has no cure. Peter Joseph died after being born prematurely due to severe HELLP syndrome experienced by Lauren at 28 weeks.
Clement and Lauren have set their goal for $1 million in donations from family and friends over the next five years. Generous donations to date have already surpassed $135,000 and pledges have reached $835,000.
The Preeclampsia Foundation's mission is to reduce maternal and infant illness and death due to preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy. As the only nonprofit in the U.S. dedicated to these diseases, the Preeclampsia Foundation is dedicated to keeping families whole.
Related Articles
Your story is needed to improve outcomes for moms like you. Add your voice to critical preeclampsia research to ensure that every story is heard.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
We provide research grant funding to advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy.
The Preeclampsia Foundation is seeking Letters of Intent for the Peter Joseph Pappas Research Grants funding program, designed to accelerate preeclampsia research. The ultimate goal of this grant prog...
A new research study suggests that blood pressure changes during the first 20 weeks of pregnancy—called blood pressure trajectories—may give providers a peek at a woman’s risk of dev...
Preeclampsia is a major cause of maternal and fetal morbidity and mortality. Prompt and accurate diagnosis is necessary to prevent adverse outcomes. A study was completed to determine the accura...
Predicting preeclampsia has proven to be a challenge. Researchers have documented many differences in early pregnancy between those who eventually develop preeclampsia and those who do not. These incl...
The U.S. Preventive Services Task Force (USPSTF) and American College of Obstetricians and Gynecologists (ACOG) guidelines changed in 2021 to help prevent preeclampsia. Low-dose aspirin has been shown...